EN | FR
EN | FR
Search
Doctor,Shows,Human,Lungs,On,Blue,Background.

Lung-On-Chip Modeling of Nanodrug Dynamics

Inhaled therapies hold enormous potential, but replicating human breathing in the lab remains a major challenge. For lung-on-chip research, airflow and mucociliary clearance are critical. Traditional aerosol systems can deliver particles, yet they rarely mimic realistic breathing patterns or the dynamic mucus environment of the respiratory tract.

A recent study by Lin et al. (2025) explores how nanodrug carriers, such as liposomes, behave under different breathing conditions. To achieve this, researchers used precise airflow control to simulate normal and pathological breathing, stable aerosol delivery into a microfluidic lung-on-chip platform, and environmental regulation (temperature and humidity) to maintain healthy airway epithelial cells.

The Role of the inExpose System

The inExpose Compact Inhalation Exposure system provided the backbone for this setup. It allowed the team to:

  • Generate programmable airflow patterns. These ranged from gentle, low shear stress (LSS) breathing to rapid, high shear stress (HSS) conditions that mimic hyperventilation.
  • Maintain physiological humidity and temperature during aerosolization.
  • Deliver aerosols into the chip with stable pressure and no backflow.
Integration with the Lung-on-Chip
The researchers combined the inExpose system with their Breathing Mucociliary-on-Chip (BMC) platform:
 
  • Upper channel: Cultured airway epithelial cells exposed to aerosolized nanodrugs.
  • Lower channel: Media perfusion mimicking blood flow.
  • Central diffuser: Ensured airtight aerosol transfer from InExpose to the chip.
This configuration enabled real-time observation of particle deposition in mucus under different airflow conditions and revealed how shear stress influences drug penetration and clearance.
 
Key Findings
  1. High shear stress (HSS) led to deeper penetration of liposomes into the mucus layer.
  2. Aerosol deposition was significantly higher under HSS compared to LSS.
  3. The system successfully replicated human-like respiratory mechanics, validating the physiological relevance of the model.
 

Pairing inExpose  with a lung-on-chip platform creates a next-generation preclinical model for inhaled nanomedicine. This approach bridges the gap between traditional in vitro assays and the complexity of the human lung. It enables researchers to design personalized inhaled therapies, predict drug clearance and efficacy with greater confidence, and develop safer, more effective nanocarrier designs.

Conclusion
This work demonstrates a practical path to realistic inhalation testing in a lung‑on‑chip platform. By controlling airflow, shear stress, and environmental conditions, researchers can model mucociliary transport and nanodrug behavior with precision. As inhaled therapies evolve, inExpose + BMC offers a robust, scalable approach for discovery and preclinical evaluation.

Featured Products

 Resources

Empowering researchers

Welcome to SCIREQ’s knowledge center. You can find everything from software registration to document downloads to complete list of SCIREQ publications in this section. Everything you need to get the most out of your SCIREQ system.